Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated With New Cancer Medicines
Sebastian Salas-Vega(London School of Economics and Political Science), Elías Mossialos(Imperial College London), Othon Iliopoulos(Massachusetts General Hospital)
Cited by 153
Related Papers
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
The primary health-care system in China
|The Lancet|2017|1.1k
European Society of Cardiology: Cardiovascular Disease Statistics 2019
|European Heart Journal|2019|1k
Quality of primary health care in China: challenges and recommendations
|The Lancet|2020|919
The impact of the COVID-19 pandemic on cancer care
|Nature Cancer|2020|597